Clinical Trial Update: Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb) [NA]

View source ↗

Summary

This clinical trial update reports on the safety, tolerability, and fat absorption of Relizorb, an enteral feeding in-line enzyme cartridge, in patients with ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• RELiZORB

Snippet

Sponsor: Alcresta Therapeutics, Inc. | Conditions: Exocrine Pancreatic Insufficiency | NA | Status: COMPLETED | Results posted: 2017-01-20